1 Tests | Rs 9100 | Blood Test Only | Fasting Not Needed
Powered By Redcliffelab

CLL Panel By FISH – Advanced Genetic Testing for Chronic Lymphocytic Leukemia

If you or your loved ones have been diagnosed with Chronic Lymphocytic Leukemia (CLL) or are suspected to have this condition, the CLL Panel By FISH is an advanced genetic test designed to provide crucial insights into the specific genetic abnormalities associated with CLL. This specialized test utilizes Fluorescence In Situ Hybridization (FISH) technology to identify specific genetic markers, aiding in accurate diagnosis and guiding targeted treatment decisions.

Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer that affects lymphocytes, a type of white blood cell. Genetic testing is essential for understanding the molecular characteristics of CLL, which can vary between individuals and influence treatment strategies.

The CLL Panel By FISH includes a comprehensive analysis of genetic abnormalities commonly found in CLL, such as deletions of 13q, 11q, and 17p regions, as well as trisomy 12. These genetic markers help classify CLL subtypes, allowing healthcare providers to design personalized therapies for better treatment responses.

With the CLL Panel By FISH results, oncologists can:

Accurately Diagnose CLL Subtypes: Identifying specific genetic abnormalities helps in accurately classifying the subtype of CLL, which may have different prognoses and responses to treatments.

Guide Treatment Decisions: Knowledge of genetic markers enables oncologists to choose the most appropriate treatment, including targeted therapies or traditional chemotherapy, to achieve the best possible outcomes.

Predict Prognosis: Genetic profiling provides critical information on the likely course of the disease, helping patients and their families make informed decisions about treatment options.

Monitor Disease Progression: Periodic testing using FISH technology helps monitor changes in genetic markers, allowing for timely adjustments to treatment plans based on disease progression.

The CLL Panel By FISH empowers you and your healthcare team with the information needed to make the best decisions for your specific CLL subtype, increasing the chances of successful treatment and better long-term outcomes.